Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Study of Sotorasib in People With Brain Tumors

ClinicalTrials.gov ID: NCT06807619

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06807619. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 21, 2026, 4:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BrainMet ADePPT (Anticancer Drug Penetration Platform Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The researchers are doing this study to find out how effective sotorasib is at getting into KRAS G12C+ brain tumors. The researchers will also find out whether sotorasib is a safe and effective treatment for people undergoing surgical resection of KRAS G12C+ metastatic brain tumors, and do tests that show how the body absorbs, distributes, and gets rid of sotorasib.

Study identification

NCT ID
NCT06807619
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Enrollment
16 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 29, 2025 (Actual)
Primary completion
Jan 2028 (Estimated)
Completion
Jan 2028 (Estimated)
Last update posted
May 22, 2026

2025 – 2028

United States locations

U.S. sites
7
U.S. states
2
U.S. cities
6
Facility City State ZIP Site status
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey 07920 Recruiting
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown New Jersey 07748 Recruiting
Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack New York 11725 Recruiting
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack New York 11725 Recruiting
Memorial Sloan Kettering West Harrison (Limited Protocol Activities) Harrison New York 10604 Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York New York 10065 Recruiting
Memorial Sloan Kettering Nassau (Limited Protocol Activities) Uniondale New York 11553 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06807619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 22, 2026 · Synced Nov 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.